Lv1
40 积分 2025-02-25 加入
PCSK9 and ANGPTL3 Inhibitors in Homozygous Familial Hypercholesterolemia: A Meta-analysis of Randomized Clinical Trials
5个月前
已完结
FlowDesign: Improved Design of Antibody CDRs Through Flow Matching and Better Prior Distributions
9个月前
已完结
OpenAI — explain why some countries are excluded from ChatGPT
10个月前
已完结
What the OpenAI drama means for AI progress — and safety
10个月前
已完结
Where Medical Statistics Meets Artificial Intelligence
10个月前
已完结
The Turing Test and our shifting conceptions of intelligence
10个月前
已关闭
Expanding the triglyceride range in clinical trials: therapeutic opportunities
11个月前
已完结
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia
11个月前
已完结
Familial Combined Hyperlipidaemia: Under - Defined and Under - Diagnosed?
1年前
已完结
Global epidemiology of dyslipidaemias
1年前
已完结
皖公网安备34019202002308
